Monitoring of Multiple Sclerosis (MS) Participants With the Use of Digital Technology (Smartphones and Smartwatches) - A Feasibility Study

CompletedNot a drug-phase studyMS (type not specified)NCT02952911

What it found

Paper found, not read

A paper reports the results; we have not read it yet. See Papers below.

What was tested

Treatment tested

  • Smartphone and Smartwatch

What it measured

Main measures

  • Compliance Level: Number of Active and Passive Tests Conducted by MS Participants and Healthy Controls in 12 Weeks

    Week 12

  • Compliance Level: Number of Active and Passive Tests Conducted by MS Participants and Healthy Controls in 24 Weeks

    Week 24

  • Satisfaction Questionnaire Score at Week 12: Assessment of MS Participants' and Healthy Volunteers' Experience Regarding Smartphone and Smartwatch Use and its Impact on Their Daily Activities

    Week 12

    Quality of life (reported by participants)
  • Satisfaction Questionnaire Score at Week 24: Assessment of MS Participants' and Healthy Volunteers' Experience Regarding Smartphone and Smartwatch Use and its Impact on Their Daily Activities

    Week 24

    Quality of life (reported by participants)

Who could take part

MS (type not specified) · 18 to 55 · EDSS 0.0 to 5.5

Show the full criteria

Inclusion criteria

For MS Participants: * Definite diagnosis of MS, confirmed as per the revised McDonald 2010 criteria * Expanded Disability Status Scale (EDSS) of 0.0 to 5.5, inclusive For All Participants: * Weight: 45 to 110 kilograms (kg)

Exclusion criteria

For MS Participants: * Severely ill and unstable participants as per investigator's discretion * Change in dosing regimen or switch of Disease Modifying Therapy (DMT) in the last 12 weeks prior to enrollment For All Participants: * Pregnant or lactating, or intending to become pregnant during the study

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

This prospective pilot study will assess the feasibility of remote participant monitoring using digital technology in participants with MS and healthy controls. At the enrollment visit, the participants as well as the healthy controls will be provided with a remote patient monitoring solution which includes preconfigured smartphone and smartwatch. The configured smartphone and smartwatch pair will contain application software that prompts the user to perform various assessments, referred to as active tests and passive monitoring. Active tests will include Hand Motor Function Test (HMFT), gait test, static balance test, electronic version of the Symbol Digit Modalities Test (eSDMT), Mood Scale Question (MSQ), MS Impact Scale (29-item scale) (MSIS-29) questionnaire, MS Symptom Tracking (MSST). Passive monitoring will be done to collect metrics on gait and mobility throughout the daily life of participants in a continuous and unobtrusive manner.

Papers

Loading reviews and guidelines…

History

    1. Started

      Nov 2016

    2. Main results due

      May 2018

    3. Finished

      May 2018

    Assembled by software from public sources.